• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Cytokinetics Incorporated - Articles and news items

Amgen logo

Amgen and Cytokinetics announce the first presentation of data from Phase 2 ATOMIC-AHF study of Omecamtiv Mecarbil

Industry news, News / 3 September 2013 / Amgen

First trial to evaluate cardiac myosin activator in patients with acute heart failure presented at ESC Congress 2013…

Amgen logo

Amgen and Cytokinetics announce expansion of license for Omecamtiv Mecarbil

Industry news, News / 12 June 2013 / Amgen

Amgen and Cytokinetics announced an expansion of their strategic collaboration…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +